Document:

<PAGE>

                                                                     EXHIBIT 3.1

                            CERTIFICATE OF AMENDMENT
                                       OF
                          CERTIFICATE OF INCORPORATION
                                       OF
                                ENDOLOGIX, INC.,
                             A DELAWARE CORPORATION

      ENDOLOGIX, INC., a corporation organized and existing under and by virtue
of the Delaware General Corporation Law (the "Corporation"), does hereby
certify:

      FIRST: At a meeting of the Board of Directors of the Corporation
resolutions were duly adopted proposing and declaring advisable the following
amendment to the Certificate of Incorporation of the Corporation, directing that
said amendment be submitted to the stockholders of the Corporation for
consideration thereof. The resolution setting forth the proposed amendment is as
follows:

            RESOLVED, that Article IV, Section (A) of the Certificate of
      Incorporation is hereby amended and restated to read in full as follows:

                                   "ARTICLE IV

            (A) Classes of Stock. This corporation is authorized to issue two
      classes of stock, to be designated, respectively, "Common Stock" and
      "Preferred Stock." The total number of shares that this corporation is
      authorized to issue is sixty-five million (65,000,000). The number of
      shares of Preferred Stock authorized to be issued is five million
      (5,000,000), par value $0.001 per share. The number of shares of Common
      Stock authorized to be issued is sixty million (60,000,000), par value
      $0.001 per share. The shares of Preferred Stock may be issued from time to
      time in one or more series. The Board of Directors of this corporation
      (the "Board of Directors") is expressly authorized to provide for the
      issue of all or any of the remaining shares of the Preferred Stock in one
      or more series, and to fix the number of shares and to determine or alter
      for each such series, such voting powers, full or limited, or no voting
      powers, and such designations, preferences, and relative, participating,
      optional, or other rights and such qualifications, limitations or
      restrictions thereof, as shall be stated and expressed in the resolution
      or resolutions adopted by the Board of Directors providing for the issue
      of such shares and as may be permitted by the General Corporation Law of
      the State of Delaware. Subject to compliance with applicable protective
      voting rights which have been granted to the Preferred Stock or series
      thereof in Certificates of Designation or the corporation's Certificate of
      Incorporation ("Protective Provisions"), but notwithstanding any other
      rights of the Preferred Stock or any series thereof, the rights,
      privileges, preferences and restrictions of any such additional series may
      be subordinated to, pari passu with (including, without limitation,
      inclusion in provisions with respect to liquidation and acquisition
      preferences, redemption and/or approval of matters by vote or written
      consent), or senior to any of those of any present or future class or
      series of Preferred or Common Stock. Subject to compliance with applicable
      Protective Provisions, the

<PAGE>

      Board of Directors is also expressly authorized to increase or decrease
      (but not below the number of shares of such series then outstanding) the
      number of shares of any series subsequent to the issue of shares of that
      series. In case the number of shares of any such series shall be so
      decreased, the shares constituting such decrease shall resume the status
      they had prior to the adoption of the resolution originally fixing the
      number of shares of such series."

      SECOND: That thereafter, pursuant to a resolution of the Board of
Directors, the Annual Meeting of the Stockholders of the Corporation was duly
called and held, upon notice in accordance with Section 222 of the Delaware
General Corporation Law, at which meeting the necessary number of shares as
required by statute were voted in favor of this amendment of the Certificate of
Incorporation.

      THIRD: The amendment of the Certificate of Incorporation herein certified
has been duly adopted in accordance with the provisions of Section 242 of the
General Corporation Law of the State of Delaware.

                            [Signature Page Follows]

                                       2
<PAGE>

      IN WITNESS WHEREOF, Endologix, Inc. has caused this Certificate of
Amendment of Certificate of Incorporation to be signed by the undersigned, and
the undersigned has executed this certificate and affirms the foregoing as true
and under penalty of perjury this 23rd day of May, 2006.

                                         /s/ Paul McCormick
                                         --------------------------------------
                                         Paul McCormick,
                                         President and Chief Executive Officer

                                       3
<PAGE>

                            CERTIFICATE OF AMENDMENT
                                       OF
                          CERTIFICATE OF INCORPORATION
                                       OF
                                ENDOLOGIX, INC.,
                             A DELAWARE CORPORATION

         ENDOLOGIX, INC., a Delaware corporation organized and existing under
and by virtue of the Delaware General Corporation Law (the "Corporation"), does
hereby certify:

         FIRST: The Board of Directors of the Corporation, by unanimous written
consent, duly adopted resolutions proposing and declaring advisable the
following amendment to the Certificate of Incorporation of the Corporation,
directing that said amendment be submitted to the stockholders of the
Corporation for consideration thereof. The resolution setting forth the proposed
amendment is as follows:

                  RESOLVED, that Article IV, Section (A) of the Certificate of
         Incorporation is hereby amended to read in full as follows:

                                   "ARTICLE IV

                  (A) Classes of Stock. This corporation is authorized to issue
         two classes of stock, to be designated, respectively, "Common Stock"
         and "Preferred Stock." The total number of shares that this corporation
         is authorized to issue is fifty-five million (55,000,000). The number
         of shares of Preferred Stock authorized to be issued is five million
         (5,000,000), par value $0.001 per share. The number of shares of Common
         Stock authorized to be issued is fifty million (50,000,000), par value
         $0.001 per share. The shares of Preferred Stock may be issued from time
         to time in one or more series. The Board of Directors of this
         corporation (the "Board of Directors") is expressly authorized to
         provide for the issue of all or any of the remaining shares of the
         Preferred Stock in one or more series, and to fix the number of shares
         and to determine or alter for each such series, such voting powers,
         full or limited, or no voting powers, and such designations,
         preferences, and relative, participating, optional, or other rights and
         such qualifications, limitations or restrictions thereof, as shall be
         stated and expressed in the resolution or resolutions adopted by the
         Board of Directors providing for the issue of such shares and as may be
         permitted by the General Corporation Law of the State of Delaware.
         Subject to compliance with applicable protective voting rights which
         have been granted to the Preferred Stock or series thereof in
         Certificates of Designation or the corporation's Certificate of
         Incorporation ("Protective Provisions"), but notwithstanding any other
         rights of the Preferred Stock or any series thereof, the rights,
         privileges, preferences and restrictions of any such additional series
         may be subordinated to, pari passu with (including, without limitation,
         inclusion in provisions with respect to liquidation and acquisition
         preferences, redemption and/or approval of matters by vote or written
         consent), or senior to any of those of any present or future class or
         series of Preferred or Common Stock. Subject to compliance with
         applicable Protective Provisions, the Board of Directors is also
         expressly authorized to increase or decrease (but not below

                                       4
<PAGE>

         the number of shares of such series then outstanding) the number of
         shares of any series subsequent to the issue of shares of that series.
         In case the number of shares of any such series shall be so decreased,
         the shares constituting such decrease shall resume the status they had
         prior to the adoption of the resolution originally fixing the number of
         shares of such series."

         SECOND: The amendment of the Certificate of Incorporation herein
certified has been duly adopted in accordance with the provisions of Section 242
of the General Corporation Law of the State of Delaware.

                            [Signature page follows]

                                       5
<PAGE>

         IN WITNESS WHEREOF, ENDOLOGIX, INC. has caused this Certificate of
Amendment to be signed by its duly authorized Chief Financial Officer this 28th
day of October, 2003.

                                           /s/ David M. Richards
                                           -------------------------------------
                                           David M. Richards,
                                           Chief Financial Officer

                                       6
<PAGE>

                            CERTIFICATE OF AMENDMENT
                                     OF THE
                          CERTIFICATE OF INCORPORATION
                                       OF
                         RADIANCE MEDICAL SYSTEMS, INC.,
                             A DELAWARE CORPORATION

         RADIANCE MEDICAL SYSTEMS, INC., a Delaware corporation organized and
existing under and by virtue of the Delaware General Corporation Law (the
"Corporation"), does hereby certify:

         FIRST: The Board of Directors of the Corporation, by unanimous written
consent, duly adopted resolutions proposing and declaring advisable the
following amendment to the Certificate of Incorporation of the Corporation,
directing that said amendment be submitted to the stockholders of the
Corporation for consideration thereof. The resolution setting forth the proposed
amendment is as follows:

                  RESOLVED, that Article I of the Certificate of Incorporation
         is hereby amended to read in full as follows:

                                   "ARTICLE I

                  The name of the corporation is Endologix, Inc."

         SECOND: That thereafter, the holders of the necessary number of shares
of capital stock of the Corporation gave their written consent in favor of the
foregoing amendment in accordance with the provisions of Section 228 of the
Delaware General Corporation Law.

         THIRD: That said amendment was duly adopted in accordance with the
provisions of Section 242 of the Delaware General Corporation Law of the State
of Delaware.

                                       7
<PAGE>

         IN WITNESS WHEREOF, RADIANCE MEDICAL SYSTEMS, INC. has caused this
Certificate of Amendment to be signed by its duly authorized Chief Financial
Officer this 31st day of May, 2002.

                                           /s/ David M. Richards
                                           -------------------------------------
                                           David M. Richards,
                                           Chief Financial Officer

                                       8
<PAGE>

                                    RESTATED
                          CERTIFICATE OF INCORPORATION
                                       OF
                         RADIANCE MEDICAL SYSTEMS, INC.

                    (PURSUANT TO SECTIONS 242 AND 245 OF THE
                GENERAL CORPORATION LAW OF THE STATE OF DELAWARE)

         Radiance Medical Systems, Inc., a corporation organized and existing
under and by virtue of the provisions of the General Corporation Law of the
State of Delaware (the "General Corporation Law").

         DOES HEREBY CERTIFY:

         FIRST: That this corporation was originally incorporated on June 2,
1993, pursuant to the General Corporation Law, under the name of Endosonics
Acquisition Corp.

         SECOND: That this Restated Certificate of Incorporation restates and
integrates and does not further amend the Certificate of Incorporation of this
corporation as theretofore amended and supplemented, and there is no discrepancy
between those provisions and the provisions of this Restated Certificate of
Incorporation.

         THIRD: That the Restated Certificate of Incorporation of this
corporation, as restated, is as follows:

                                   ARTICLE I

         The name of this corporation is Radiance Medical Systems, Inc.

                                   ARTICLE II

         The address of the registered office of this corporation in the State
of Delaware is 2711 Centreville Road, Suite 400, Wilmington, Delaware, 19808
County of New Castle. The name of its registered agent at such address is The
Prentice-Hall Corporation System, Inc.

                                  ARTICLE III

         The nature of the business or purposes to be conducted or promoted is
to engage in any lawful act or activity for which corporations may be organized
under the General Corporation Law of Delaware.

                                   ARTICLE IV

         (A) Classes of Stock. This corporation is authorized to issue two
classes of stock, to be designated, respectively, "Common Stock" and "Preferred
Stock." The total number of shares that this corporation is authorized to issue
is thirty-five million (35,000,000). The number of shares of Preferred Stock
authorized to be issued is five million (5,000,000), par value

                                       9
<PAGE>

$0.001 per share. The number of shares of Common Stock authorized to be issued
is thirty million (30,000,000), par value $0.001 per share. The shares of
Preferred Stock may be issued from time to time in one or more series. The Board
of Directors of this corporation (the "Board of Directors") is expressly
authorized to provide for the issue of all or any of the remaining shares of the
Preferred Stock in one or more series, and to fix the number of shares and to
determine or alter for each such series, such voting powers, full or limited, or
no voting powers, and such designations, preferences, and relative,
participating, optional, or other rights and such qualifications, limitations or
restrictions thereof, as shall be stated and expressed in the resolution or
resolutions adopted by the Board of Directors providing for the issue of such
shares and as may be permitted by the General Corporation Law of the State of
Delaware. Subject to compliance with applicable protective voting rights which
have been granted to the Preferred Stock or series thereof in Certificates of
Designation or the corporation's Certificate of Incorporation ("Protective
Provisions"), but notwithstanding any other rights of the Preferred Stock or any
series thereof, the rights, privileges, preferences and restrictions of any such
additional series may be subordinated to, pari passu with (including, without
limitation, inclusion in provisions with respect to liquidation and acquisition
preferences, redemption and/or approval of matters by vote or written consent),
or senior to any of those of any present or future class or series of Preferred
or Common Stock. Subject to compliance with applicable Protective Provisions,
the Board of Directors is also expressly authorized to increase or decrease (but
not below the number of shares of such series then outstanding) the number of
shares of any series subsequent to the issue of shares of that series. In case
the number of shares of any such series shall be so decreased, the shares
constituting such decrease shall resume the status they had prior to the
adoption of the resolution originally fixing the number of shares of such
series.

         (B) Common Stock.

         1. Dividend Rights. Subject to the prior rights of holders of all
classes of stock at the time outstanding having prior rights as to dividends,
the holders of the Common Stock shall be entitled to receive, when and as
declared by the Board of Directors, out of any assets of this corporation
legally available therefor, such dividends as may be declared from time to time
by the Board of Directors.

         2. Liquidation Rights. Upon the liquidation, dissolution or winding up
of this corporation, the assets of this corporation shall be distributed among
the holders of Common Stock pro rata based on the number of shares of Common
Stock held by each.

         3. Redemption. The Common Stock is not redeemable.

         4. Voting Rights. The holder of each share of Common Stock shall have
the right to one vote, and shall be entitled to notice of any stockholders'
meeting in accordance with the Bylaws of this corporation, and shall be entitled
to vote upon such matters and in such manner as may be provided by law.

                                   ARTICLE V

         A director of this corporation shall not be personally liable to this
corporation or its stockholders for monetary damages for breach of fiduciary
duty as a director, except for liability (i) for any breach of the director's
duty of loyalty to this corporation or its stockholders, (ii) for acts or

                                       10
<PAGE>

omissions not in good faith or which involve intentional misconduct or a knowing
violation of law, (iii) under Section 174 of the Delaware General Corporation
Law, or (iv) for any transaction from which the director derived any improper
personal benefit. If the Delaware General Corporation Law is amended after
approval by the stockholders of this Article to authorize corporation action
further eliminating or limiting the personal liability of directors, then the
liability of a director of this corporation shall be eliminated or limited to
the fullest extent permitted by the Delaware General Corporation Law, as so
amended.

         Any repeal or modification of the foregoing paragraph by the
stockholders of this corporation shall not adversely affect any right or
protection of a director of this corporation existing at the time of such repeal
or modification.

                                   ARTICLE VI

         This corporation reserves the right to amend, alter, change or repeal
any provision contained in this Amended and Restated Certificate of
Incorporation, in the manner now or hereafter prescribed by statute, and all
rights conferred upon stockholders herein are granted to this reservation.

                                  ARTICLE VII

         The Board of Directors may from time to time make, amend, supplement or
repeal the Bylaws; provided, however, that the stockholders may change or repeal
any Bylaw adopted by the Board of Directors; and provided, further, that no
amendment or supplement to the Bylaws adopted by the Board of Directors shall
vary or conflict with any amendment or supplement adopted by the stockholders.

                                  ARTICLE VIII

         The number of directors of this corporation shall be fixed from time to
time by a bylaw or amendment thereof duly adopted by the Board of Directors or
by the stockholders. The current Board of Directors shall be divided into three
(3) classes, as nearly equal in number as possible, designated Class I, Class II
and Class III. The number of directors constituting each Class shall be fixed
from time to time by a resolution duly adopted by the Board of Directors. Class
I directors shall hold office for an initial term expiring at the annual meeting
of stockholders in 1999. Class II directors shall hold office for an initial
term expiring at the annual meeting of stockholders in 2000, and Class III
directors shall hold office for a term expiring at the annual meeting of
stockholders in 2001. At each annual meeting of stockholders held thereafter,
directors shall be elected for a three-year term to succeed the directors of the
Class whose terms then expire.

                                   ARTICLE IX

         Elections of directors need not be by written ballot unless the Bylaws
of this corporation shall so provide.

                                   ARTICLE X

         Meetings of stockholders may be held within or without the State of
Delaware, the Bylaws may provide. The books of this corporation may be kept
(subject to any provision contained in the

                                       11
<PAGE>

statutes) outside the State of Delaware at such place or places as may be
designated from time to time by the Board of Directors or in the Bylaws of this
corporation."

         FOURTH: That the Restated Certificate of Incorporation was duly adopted
by the board of directors without a vote of the stockholders in accordance with
Section 245(b) of the General Corporation Law.

         IN WITNESS WHEREOF, this Restated Certificate of Incorporation has been
signed by the Vice President, Finance and Administration, Chief Financial
Officer as of March 12, 2001.

                                              /s/ Stephen R. Kroll
                                              ----------------------------------
                                              Stephen R. Kroll
                                              Vice President, Finance and
                                              Administration, Chief Financial
                                              Officer and Secretary

                                       12Exhibit 10.1

 August 1, 2006

VIA HAND DELIVERY

Mr. Jeffrey E. Horn

815 E. Birch Avenue

Whitefish Bay, WI 53217

RE:

Separation Agreement

Dear Jeff:

This will confirm our proposal concerning your resignation from employment with ARI Network Services, Inc. (“Company”) which is effective on August 1, 2006 (“Resignation Date”).  In connection with the resignation, the Company offers you the following:

(1)

Unconditional Assistance Benefits.  Whether or not you choose to sign this agreement and accept the terms it contains or, having done so, exercise your rights to revoke your acceptance of these terms (described more fully in Paragraph 4(D), below), the following circumstances will apply:

(A)

By no later than the first Company pay date following the Resignation Date, the Company will pay you, subject to normal deductions for income and employment taxes, your regular base salary (together with any vacation that you have accrued but not used) through the Resignation Date;

(B)

You will retain all your vested rights, if any, as of the Resignation Date in the Company’s 401(k) plan and will receive all payments due you under the terms of that plan;

(C)

You will retain your right to payment of the fourth quarter installment of the fiscal 2006 current year bonus, the amount of which is not yet known, and payment of the amount, subject to normal deductions for income and employment tax withholding, will be made in a paycheck to be issued to you by the Company at the time that payments are made to the Company’s other executive officers.  Pursuant to the Company’s executive bonus arrangements, you forfeit all rights to any fiscal 2007 current year bonus and all rights to any long-term bonus not yet paid to you, including the fiscal 2006 payment under the long-term bonus arrangement;

(D)

You will retain your right to payment of commissions for July 2006, the amount of which is not yet known, and payment of the amount, subject to normal deductions for income and employment tax withholding, will be made in a paycheck to you by the Company on or about August 25, 2006.  You are not entitled to any commissions for sales after July 31, 2006;

Jeffrey Horn

August 1, 2006

Page 2

(E)

You and the Company are currently parties to one or more stock option agreements (“Option Agreements”), and the Option Agreements, together with each of their associated stock option plans (“Stock Option Plans”), provide you with the option to purchase certain shares of Company stock pursuant to their terms.  If you do not sign this agreement or if, after signing it, you revoke your acceptance of it pursuant to Paragraph 4(D), below, your outstanding stock options under the Option Agreements and Stock Option Plans will remain exercisable following the Resignation Date as provided in the Option Agreements and Stock Option Plans governing any particular set of stock options.  However, as described in Paragraph 3, below, if you sign this agreement and do not exercise your rights to revoke it (pursuant to Paragraph 4(D), below), you will forfeit all of your stock options under the Option Agreements and Stock Option Plans.  In no case, may you both exercise your options under the Option Agreements and Stock Option Plans and be paid the separation payment described in Paragraph 2, below;

(F)

The Company will provide you with the right to participate, commencing September 1, 2006, at your own expense, in the Company’s group health insurance plan in accordance with the mandates of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”); and

(G)

You must return to the Company all of its property and all of the property of its present and former officers, directors, stockholders, members, partners, agents, employees and customers which you possess or over which you have direct or indirect control, including, but not limited to, all monies, records, files, credit cards, keys, beepers, and electronically encoded information such as computer disks, etc., and all copies of such Company property (collectively, “Company Property”); provided you may retain the laptop computer you currently use if you first return it to the Company to be cleared of all Company information, files and other property in a manner satisfactory to the Company and you may retain your cellular phone if you remain responsible for all cellular charges after July 31, 2006.

(2)

Conditional Assistance Benefits. In consideration of your undertakings set forth in Paragraph 3, below, and conditioned upon (i) your acceptance of the terms contained in this agreement and (ii) your decision not to exercise your revocation rights (described in Paragraph 4(D), below), the Company will pay you, as a separation payment, a total of $42,469 in a lump sum in lieu of any salary after the Resignation Date.  This separation payment will be made to you by the Company no later than 10 business days following expiration of the Revocation Period (described below) and will be subject to normal deductions for income and employment tax withholding.  

(3)

Your Undertakings.  In exchange for the benefits provided to you under Paragraph 2, above, you agree as follows:

Jeffrey Horn

August 1, 2006

Page 3

(A)

You agree, on behalf of yourself, your heirs, successors and assigns, to release the Company, its affiliates and subsidiaries and their respective past and present officers, directors, stockholders, members, partners, agents and employees (“Released Parties”) from any claims arising on or before the date you sign this agreement.  This includes, but is not limited to, giving up any claims related in any way to your employment by the Company, the decision to terminate your employment, termination of our employment relationship, and wages and other remuneration, including, but not limited to, any current or former bonus or other incentive plans or programs offered by the Company, but does not include your compensation and other rights as set forth in this Agreement.  This release of claims includes any claims, whether they are presently known or unknown, or anticipated or unanticipated by you.  Because you are age 40 or older, your acceptance of this agreement also will release any and all claims under the federal Age Discrimination in Employment Act.  You should not construe this reference to age discrimination claims as in any way limiting the general and comprehensive nature of the release of claims provided under this Paragraph 3(A).  You agree to waive and give up any benefit conferred on you by any order or judgment issued in connection with any proceeding filed against the Released Parties regarding any claim released in this agreement;

(B)

You represent and warrant that as of the date of your signing of this agreement, you do not have within your possession or control any Company Property (defined above), except the computer and cellular phone referenced in Paragraph 1(G);

(C)

You agree that for 12 months following the Resignation Date, you will not directly or indirectly attempt to sell to any Restricted Customer (defined below) any goods, products or services of the type or substantially similar to the type sold by the Company during the 12 months prior to the Resignation Date.  The term “Restricted Customer” means any individual or entity (i) for whom/which the Company provided or licensed software, products or services and (ii) with whom/which you or the employees whom you directly supervised had direct contact on behalf of the Company, or about whom/which you acquired non-public information in connection with your employment by the Company, during the 12 months preceding the Resignation Date, including prospective Company customers;

(D)

You agree that for 18 months following the Resignation Date you will not directly or indirectly encourage any Company employee to terminate his/her employment with the Company or solicit such an individual for employment outside the Company in any manner which would end or diminish that employee’s services to the Company;

(E)

You agree not to engage at any time in any form of conduct or make any statements or representations, or direct any other person or entity to engage in any conduct or make any statements or representations, that disparage, criticize or otherwise impair the reputation of the Company or any of the Released Parties (defined above).  Nothing 

Jeffrey Horn

August 1, 2006

Page 4

contained in this Paragraph 3(F) shall preclude you from providing truthful testimony pursuant to subpoena or other legal process; 

(F)

You agree until August 15, 2006, to make yourself reasonably available upon request from time to time to provide information and consult with the Company and otherwise assist with the transition of your responsibilities to other employees of the Company; and

(G)

You agree to forfeit all of your stock options under the Option Agreements and Stock Option Plans.  In no case, may you both exercise your options under the Option Agreements and Stock Option Plans and be paid the separation payment described in Paragraph 2.

(4)

Acceptance Procedures.  The Company wishes to ensure that you voluntarily agree to the terms contained in this agreement and do so only after you fully understand them.  Accordingly, the following procedures shall apply:

(A)

You agree and acknowledge that you have read this agreement, understand its contents, and may agree to the terms of this agreement by signing and dating it and returning the signed and dated agreement, via mail, overnight delivery or hand delivery, so that it is received by Mary Pierson, ARI Network Services, Inc., 11425 West Lake Park Drive, Suite 900, Milwaukee, Wisconsin, 53224, on or before 5:00 p.m. Central time on the 25th calendar date following your receipt of this agreement.  The sooner you sign and return this agreement to the Company, the sooner you will receive the benefits described in Paragraph 2, above;

(B)

You agree and acknowledge that you have been advised by the Company to consult with an attorney prior to signing this agreement;

(C)

You understand that this agreement, at Paragraph 3(A), above, inclu­des a final general release, including a release of all claims under the Age Discrimination in Employment Act;

(D)

You understand that you have seven (7) calendar days after signing this agreement within which to revoke your acceptance of it (“Revocation Period”).  Such revocation will not be effective unless written notice of the revocation is, via mail, overnight delivery or hand delivery, directed to and received by Mary Pierson, ARI Network Services, Inc., 11425 West Lake Park Drive, Suite 900, Milwaukee, Wisconsin, 53224, on or before 5:00 p.m. Central time on the first work day following the end of the Revocation Period;

(E)

This agreement will not be binding or enforceable unless you have signed and delivered it as provided in Paragraph 4(A), above, and have chosen not to exercise your 

Jeffrey Horn

August 1, 2006

Page 5

revocation rights, as described in Paragraph 4(D), above.  If you give timely notice of your intention to revoke your acceptance of the terms set forth in this agreement, it shall become null and void, and all rights and claims of the parties which would have existed, but for the acceptance of this agreement’s terms, shall be restored; and

(F)

You represent and warrant to the Company that, in the event, you choose to accept the terms of this agreement by signing it, the date and time appearing above your name on the last page of this agreement shall be the actual date and time on which you have signed the agreement.

(5)

Miscellaneous.  Should you accept the terms of this agreement, its terms will be governed by the following:

(A)

This agreement constitutes the complete understanding between you and the Company concerning all matters affecting your employment with the Company and the separation thereof.  If you accept this agreement, it supersedes all prior agreements, understandings and practices concerning such matters, including, but not limited to, any Company personnel documents, handbooks, policies, incentive or bonus plans or programs (including any executive bonus arrangements), and any prior customs or practices of the Company; provided, however, that this Paragraph 5(A) does not apply to any confidentiality, non-competition or other restrictive covenant obligations that you owe to the Company (including the Confidentiality Agreement dated December 4, 2000) which shall survive and remain in full force and effect following the Resignation Date;  

(B)

If any court of competent jurisdiction determines that any of the provisions of Paragraphs 3(D)-(E), above, are invalid or unenforceable, then such invalidity or unenforceability shall have no effect on the other provisions of Paragraphs 3(D)-(E) or this agreement which shall remain valid, binding and enforceable and in full force and effect, and, to the extent allowed by law, such invalid or unenforceable provision shall be construed in a manner so as to give the maximum valid and enforceable effect to the intent of the parties expressed therein;

(C)

Nothing in the release contained in this agreement should be construed as an admission of wrongdoing or liability on the part of the Company.  The Company denies any liability to you;

(D)

This document and its interpretation shall be governed and construed in accordance with the laws of the State of Wisconsin and shall be binding upon the parties hereto and their respective successors and assigns;

(E)

In the event that you breach any provision of this agreement, you agree that the Company may suspend all additional payments under this agreement, recover any damages suffered as a result of such breach and recover from you any reasonable attorneys’ 

Jeffrey Horn

August 1, 2006

Page 6

fees and costs it incurs as a result of your breach.  In addition, you agree that the Company may seek injunctive or other equitable relief as a result of a breach by you of any provisions of this agreement; and

(F)

You understand and acknowledge that pursuant to law, a copy of this agreement will be filed with the United States Securities and Exchange Commission (“SEC”) and that, as a result, the terms of this agreement will be public. 

This agreement is intended to resolve all outstanding issues between you and the Company in a comprehensive manner.  Although the agreement contains language releasing the Company from claims, the Company maintains, and you understand and acknowledge that the Company maintains, that you have no such claims against the Company or any of the parties covered by the release contained in Paragraph 3(A), above.

Should you have any questions, please feel free to contact Mary Pierson.

Very truly yours,

ARI NETWORK SERVICES, INC.

By:

/s/ Brian E. Dearing                             

Brian E. Dearing

Chairman and Chief Executive Officer

I agree with and accept the terms contained in 

this agreement and agree to be bound by them.  

Dated this 1st day of August, 2006.

Time:  12:15 p.m.                                        

/s/ Jeffrey Horn                                           

Jeffrey Horn

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}]]